← All trials
NCT03566485
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 25, 2018
- Primary completion
- Jul 31, 2023
- Completion date
- Jul 31, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vanderbilt UniversityLead sponsor
- Vanderbilt UniversityReponsible party - principal investigator
- Vanderbilt UniversityOverall official - principal investigator
- GenentechCollaborator
- Stand Up To CancerCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.